RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.
Atsushi TanakaKeiji TsujiYasuyuki KomiyamaKota TsuruyaKeisuke KakisakaAkemi TsutsuiKeiko IchimotoMasayuki UenoYuki OkazakiHiroteru KamimuraAtsushi TakaiNoriyo YamashikiTakanori ItoMasaaki WatanabeMasanori AbeKen-Ichi HaradaTatehiro KagawaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)
RECAM-J 2023, when prospectively used without any missing hepatitis virus markers, provides acceptable performance for identifying at least PR DILI cases in Japanese daily clinical practice.